微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 23.88% | -20.8% | 11.98% | 126/157 | 48.88% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 21.33% | -39.7% | -9.7% | 137/157 | 50.55% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 23.62% | -14.9% | -9.01% | 129/157 | 50.61% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 25.96% | -3.77% | -13.91% | 125/157 | -2.2% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 30.15% | 16.82% | -14.75% | 117/157 | 14.82% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 35.37% | 39.24% | 27.43% | 101/157 | 31.96% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 27.76% | 4.19% | 2.89% | 123/157 | 51.88% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 26.98% | 3.24% | 4.52% | 122/157 | 22.51% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 25.81% | 6.31% | 1.61% | 125/157 | 33.12% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 25.4% | 14.22% | -4.65% | 126/157 | 51.76% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 26.64% | 16.75% | 1.95% | 125/157 | 51.61% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 26.13% | 21.73% | 7.62% | 126/157 | 32.47% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 24.28% | 12.34% | 9.17% | 130/157 | 38.42% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 22.24% | -9.94% | -2.54% | 128/157 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 22.82% | -19.17% | 6.31% | 136/157 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 21.46% | -30.36% | -0.68% | 131/157 | 5.64% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 21.61% | -35.63% | -12.48% | 135/157 | 20.99% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 24.69% | -26.4% | -12.53% | 124/157 | 54.39% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 28.23% | -16.9% | -8.41% | 130/157 | 55.2% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 30.82% | -15.73% | -8.2% | 112/157 | 46.77% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 33.58% | -11.12% | 0.08% | 115/157 | 47.23% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 33.55% | 2% | -1.24% | 97/157 | 54.13% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 33.97% | -2.94% | -7.13% | 120/157 | -148.64% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 36.58% | 2% | -3.17% | 96/157 | 56.43% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 37.78% | 10.65% | 7.94% | 100/157 | 54.17% | 微芯生物 | 95.14% | 行业排名> |
| 2019-12-31 | 35% | 5.88% | 2.52% | 109/157 | -1242.15% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-06-30 | 34.14% | 2% | 3.28% | 93/157 | 55.21% | 微芯生物 | 95.81% | 行业排名> |
| 2018-12-31 | 33.05% | 9.31% | 9.31% | 106/157 | -211.97% | 微芯生物 | 96.09% | 行业排名> |
| 2017-12-31 | 30.24% | -8.59% | -8.59% | 103/157 | 52.55% | 微芯生物 | 96.11% | 行业排名> |
| 2016-12-31 | 33.08% | 2% | 2% | 81/157 | 48.46% | 微芯生物 | 95.5% | 行业排名> |